Published in Curr Opin Genet Dev on October 14, 2014
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell (2006) 120.51
Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell (2007) 101.42
Identification of human brain tumour initiating cells. Nature (2004) 38.87
Establishment in culture of pluripotential cells from mouse embryos. Nature (1981) 30.49
Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells. Cell (2011) 7.30
Single-cell expression analyses during cellular reprogramming reveal an early stochastic and a late hierarchic phase. Cell (2012) 7.17
Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature (2008) 7.07
Pioneer transcription factors: establishing competence for gene expression. Genes Dev (2011) 6.01
Human embryonic stem cells derived by somatic cell nuclear transfer. Cell (2013) 5.91
Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state. Proc Natl Acad Sci U S A (2011) 5.53
Pluripotency and cellular reprogramming: facts, hypotheses, unresolved issues. Cell (2010) 5.13
Cancer stem cells: current status and evolving complexities. Cell Stem Cell (2012) 5.07
The promise of induced pluripotent stem cells in research and therapy. Nature (2012) 5.05
Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science (2013) 4.94
Cancer stem cells: an evolving concept. Nat Rev Cancer (2012) 4.57
Making a tumour's bed: glioblastoma stem cells and the vascular niche. Nat Rev Cancer (2007) 4.54
A molecular roadmap of reprogramming somatic cells into iPS cells. Cell (2012) 4.41
Facilitators and impediments of the pluripotency reprogramming factors' initial engagement with the genome. Cell (2012) 3.80
Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity. Cell (2013) 3.61
Multilineage differentiation from human embryonic stem cell lines. Stem Cells (2001) 3.22
Dedifferentiation of committed epithelial cells into stem cells in vivo. Nature (2013) 2.85
Premature termination of reprogramming in vivo leads to cancer development through altered epigenetic regulation. Cell (2014) 2.82
Cancer stem cells: the challenges ahead. Nat Cell Biol (2013) 2.78
Systems-level dynamic analyses of fate change in murine embryonic stem cells. Nature (2009) 2.70
Induction of pluripotency in mouse somatic cells with lineage specifiers. Cell (2013) 2.69
Uncovering early response of gene regulatory networks in ESCs by systematic induction of transcription factors. Cell Stem Cell (2009) 2.32
Differentiated Troy+ chief cells act as reserve stem cells to generate all lineages of the stomach epithelium. Cell (2013) 2.10
Mechanisms and models of somatic cell reprogramming. Nat Rev Genet (2013) 2.09
A precarious balance: pluripotency factors as lineage specifiers. Cell Stem Cell (2011) 2.07
Quantifying the Waddington landscape and biological paths for development and differentiation. Proc Natl Acad Sci U S A (2011) 2.00
Origins and implications of pluripotent stem cell variability and heterogeneity. Nat Rev Mol Cell Biol (2013) 1.91
The nature of stem cells: state rather than entity. Nat Rev Genet (2004) 1.75
Genetic and epigenetic variations in iPSCs: potential causes and implications for application. Cell Stem Cell (2013) 1.63
Lineage conversion methodologies meet the reprogramming toolbox. Nat Cell Biol (2012) 1.56
Reprogramming of human fibroblasts to pluripotency with lineage specifiers. Cell Stem Cell (2013) 1.45
Rethinking differentiation: stem cells, regeneration, and plasticity. Cell (2014) 1.41
Establishment of pluripotential cell lines from haploid mouse embryos. J Embryol Exp Morphol (1983) 1.36
Maintaining differentiated cellular identity. Nat Rev Genet (2012) 1.32
Discovering pluripotency: 30 years of mouse embryonic stem cells. Nat Rev Mol Cell Biol (2011) 1.31
Molecular control of induced pluripotency. Cell Stem Cell (2014) 1.22
Statistical mechanics of pluripotency. Cell (2013) 1.16
Maintenance of embryonic stem cell pluripotency by Nanog-mediated reversal of mesoderm specification. Nat Clin Pract Cardiovasc Med (2006) 1.15
Identification of brain tumour initiating cells using the stem cell marker aldehyde dehydrogenase. Eur J Cancer (2013) 0.90
Uncovering the true identity of naïve pluripotent stem cells. Trends Cell Biol (2013) 0.89
Rolling ES cells down the Waddington landscape with Oct4 and Sox2. Cell (2011) 0.87
Mathematical approaches to modeling development and reprogramming. Proc Natl Acad Sci U S A (2014) 0.87
Stem cells: Surf the waves of reprogramming. Nature (2013) 0.85
Understanding the roadmaps to induced pluripotency. Cell Death Dis (2014) 0.85
Dedifferentiation, transdifferentiation, and reprogramming: future directions in regenerative medicine. Semin Reprod Med (2013) 0.84
Understanding impediments to cellular conversion to pluripotency by assessing the earliest events in ectopic transcription factor binding to the genome. Cell Cycle (2013) 0.83
Lineage specifiers: new players in the induction of pluripotency. Genomics Proteomics Bioinformatics (2013) 0.81
New balance in pluripotency: reprogramming with lineage specifiers. Cell (2013) 0.80
Reprogramming development and aging: cell differentiation as a malleable process. Curr Opin Cell Biol (2012) 0.78
Developmental biology: A cellular view of regeneration. Nature (2009) 0.78
Aging stem cells. A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging. Science (2015) 2.60
Targeted gene correction minimally impacts whole-genome mutational load in human-disease-specific induced pluripotent stem cell clones. Cell Stem Cell (2014) 2.24
3D Culture Supports Long-Term Expansion of Mouse and Human Nephrogenic Progenitors. Cell Stem Cell (2016) 0.77
Regeneration: making muscle from hPSCs. Cell Res (2014) 0.75
Integration of CpG-free DNA induces de novo methylation of CpG islands in pluripotent stem cells. Science (2017) 0.75